BioCentury

7:00 AM GMT, Jun 9, 2003
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

OvaRex MAb: Phase II data; Phase III

In a Phase II trial in 145 patients, the median time to disease relapse for OvaRex

Read the full 166 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.